Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.42M | -8.30M | -7.93M | -8.50M | -6.86M |
| Total Depreciation and Amortization | 2.35M | 2.36M | 2.39M | 2.43M | 2.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06M | 855.00K | 1.11M | 1.17M | 1.70M |
| Change in Net Operating Assets | -657.00K | -629.00K | 264.00K | -1.01M | -763.00K |
| Cash from Operations | -4.67M | -5.72M | -4.18M | -5.92M | -3.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.68M | 5.46M | 4.01M | -4.67M | 1.98M |
| Cash from Investing | 13.68M | 5.46M | 4.01M | -4.67M | 1.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.29M | -20.00K | -18.00K | -1.89M | -1.52M |
| Issuance of Common Stock | 620.00K | 705.00K | 1.75M | 12.94M | 3.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -26.00K | -28.00K | -130.00K | -969.00K | -104.00K |
| Cash from Financing | -9.69M | 657.00K | 1.60M | 10.08M | 1.47M |
| Foreign Exchange rate Adjustments | 1.00K | 5.00K | 7.00K | 15.00K | -24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -681.00K | 403.00K | 1.44M | -497.00K | -63.00K |